499 related articles for article (PubMed ID: 18074733)
41. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
[TBL] [Abstract][Full Text] [Related]
42. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
43. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.
Luef G; Rauchenzauner M; Waldmann M; Sturm W; Sandhofer A; Seppi K; Trinka E; Unterberger I; Ebenbichler CF; Joannidis M; Walser G; Bauer G; Hoppichler F; Lechleitner M
Epilepsy Res; 2009 Sep; 86(1):42-7. PubMed ID: 19464851
[TBL] [Abstract][Full Text] [Related]
44. [Correlations of serum alanine aminotransferase and insulin resistance, pancreatic B-cell function].
Wang YH; Li M; Gao S; Zhang XJ; Li LX; Zhang K
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(48):3426-30. PubMed ID: 22333257
[TBL] [Abstract][Full Text] [Related]
45. Liver function test changes in centrally obese youth with metabolic syndrome in a Serbian population.
Dimitrijevic-Sreckovic V; Soldatovic I; Culafic D; Sreckovic B; Popovic S; Djordjevic P; Ille T
Metab Syndr Relat Disord; 2013 Dec; 11(6):427-33. PubMed ID: 23931675
[TBL] [Abstract][Full Text] [Related]
46. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
Liver Int; 2009 Apr; 29(4):525-9. PubMed ID: 19323780
[TBL] [Abstract][Full Text] [Related]
47. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
Sterling RK; Smith PG; Brunt EM
J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
[TBL] [Abstract][Full Text] [Related]
48. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Alami F; Alizadeh M; Shateri K
Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
[TBL] [Abstract][Full Text] [Related]
49. Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
Bril F; McPhaul MJ; Kalavalapalli S; Lomonaco R; Barb D; Gray ME; Shiffman D; Rowland CM; Cusi K
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4360-e4371. PubMed ID: 34190318
[TBL] [Abstract][Full Text] [Related]
50. Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia.
Su CC; Wang K; Hsia TL; Chen CS; Tung TH
J Clin Gastroenterol; 2006 Jul; 40(6):551-4. PubMed ID: 16825939
[TBL] [Abstract][Full Text] [Related]
51. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes.
Shin JY; Kim SK; Lee MY; Kim HS; Ye BI; Shin YG; Baik SK; Chung CH
Diabetes Res Clin Pract; 2011 Oct; 94(1):156-62. PubMed ID: 21862168
[TBL] [Abstract][Full Text] [Related]
52. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
53. Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth.
Klein M; Iazzettii L; Speiser P; Carey D; Shelov S; Accacha S; Fennoy I; Rosenbaum M; Rapaport R
J Diabetes; 2015 Sep; 7(5):649-56. PubMed ID: 25266069
[TBL] [Abstract][Full Text] [Related]
54. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
55. Fatty liver--an additional and treatable feature of the insulin resistance syndrome.
Knobler H; Schattner A; Zhornicki T; Malnick SD; Keter D; Sokolovskaya N; Lurie Y; Bass DD
QJM; 1999 Feb; 92(2):73-9. PubMed ID: 10209658
[TBL] [Abstract][Full Text] [Related]
56. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
57. Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Nutr Hosp; 2010; 25(5):730-5. PubMed ID: 21336428
[TBL] [Abstract][Full Text] [Related]
58. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
Iacobellis G; Moschetta A; Buzzetti R; Ribaudo MC; Baroni MG; Leonetti F
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):442-7. PubMed ID: 17134955
[TBL] [Abstract][Full Text] [Related]
59. General Lack of Correlations between Age and Signs of the Metabolic Syndrome in Subjects with Non-diabetic Fasting Glucose Values.
Preuss HG; Mrvichin N; Clouatre D; Bagchi D; Preuss JM; Perricone NV; Swaroop A; Kaats GR
J Am Coll Nutr; 2017; 36(7):556-564. PubMed ID: 28895791
[TBL] [Abstract][Full Text] [Related]
60. Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women.
Sinn DH; Gwak GY; Rhee SY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
Digestion; 2015; 91(2):150-7. PubMed ID: 25677815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
